SCA Pharmaceuticals Recalls Buffered Lidocaine Syringes Due to Sterility Concerns
SCA Pharmaceuticals is recalling 3,793 syringes of Buffered Lidocaine HCl due to a potential defective cap that compromises sterility. The product was distributed to hospitals nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. According to the rubric, an FDA Class II recall involving a risk of serious health consequences (loss of sterility in an injectable drug) is categorized as Severe.
Plain-English summary
SCA Pharmaceuticals is voluntarily recalling 3,793 syringes of Buffered Lidocaine HCl, 1%, 5 mL with Sodium Bicarbonate Injection. The recall is being conducted because of a lack of assurance of sterility, which may be caused by a defective syringe cap resulting in a non-integral unit.
The affected product is a prescription-only local anesthetic used in single-dose syringes. The specific lots involved are 1220023305, 12200223400, 1220023536, 1220023608, 1220023811, and 1220023812, with expiration dates ranging from December 17, 2020, to December 27, 2020.
The product was distributed to hospitals nationwide. Healthcare facilities should stop using the affected syringes and contact SCA Pharmaceuticals for further instructions regarding the return or disposal of the product.
The recalled product
- Product
- Buffered Lidocaine HCl, 1%, 5 mL (10mg/mL) with Sodium Bicarbonate Injection for Local Anesthetic Use, 5 mL Single Dose Syringe, Rx Only SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004072509
- Manufacturer
- SCA Pharmaceuticals
- Category
- Drug — Injectable Anesthetic
- Hazard
- Affected units
- 3,793
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (11)
- Lot # 1220023305
- BUD 12/17/2020
- 12200223400
- BUD 12/19/2020
- 1220023536
- BUD 12/25/2020
- 1220023608
- BUD 12/27/2020
- 1220023811
- BUD 12/26/2020 & 1220023812
- BUD 12/26/2020.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 32 recalled by SCA Pharmaceuticals under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 32 products in this recall →Related recalls
Same manufacturer · SCA Pharmaceuticals
See all →- HighSCA Pharmaceuticals Fentanyl-Bupivacaine Injectable Recall Due to Manufacturing Deviations
FDA (Drugs) · 2023-08-02
- ModerateFDA recalls Oxytocin product for low potency nationwide
FDA (Drugs) · 2023-05-03
- ModerateFentanyl Injection Syringes Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2023-03-08
- ModerateNorepinephrine Injection Recalled Nationwide for Manufacturing Quality Deviations
FDA (Drugs) · 2022-05-11
- ModerateDrug recall: fentanyl and bupivacaine injectable solution manufacturing deviations
FDA (Drugs) · 2022-05-11
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29